Directory - College of Pharmacy - University of Arizona

J Lyle Bootman, PhD, ScD

Dean;
Professor of Pharmacy,
Medicine, and Public Health;
Founding Executive Director,
Center for Health Outcomes and Pharmacoeconomic Research

Department:
Pharmacy Administration

Primary Phone:
(520) 626-1657
Fax:
(520) 626-0546

E-mail:

Location:
Drachman Hall B307B

Bio / Research:

J. Lyle Bootman is dean of the college and professor of pharmacy practice, pharmaceutical sciences, medicine and public health. He also holds the title of founding and executive director of the Center for Health Outcomes and PharmacoEconomic Research (HOPE research center) at the College of Pharmacy.

Dean Bootman served as the 1999-2000 president of the American Pharmaceutical Association (APhA) and the Pharmacy and Therapeutics Society. His current research efforts include outcomes and pharmaceconomics research, pharmacoepidemiology and international pharmacy systems. Specifically, Dr. Bootman investigates the incidence and drug-related morbidity and mortality from a clinical and economic perspective.

He has received numerous scientific and national awards and honors. He is a member of the Institute of Medicine of the National Academies.

Education:

University of Arizona, College of Pharmacy BS 1974 Pharmacy
University of Minnesota MS 1976 Pharmacy Administration
University of Minnesota PhD 1978 Pharmacy Administration

Honors, Awards, and Fellowships
1970-1974 Health Professions Scholarship, The University of Arizona College of Pharmacy
1970-1974 Dean's Honor List, University of Arizona College of Pharmacy
1973 Outstanding Junior, Kappa Psi Pharmacy Fraternity, The University of Arizona
1973 Outstanding Junior, Alpha Zeta Omega Award, The University of Arizona
1973 Elected to Rho Chi National Pharmacy Honorary Society and served as President, 1973 - 1974
1974 Phi Kappa Phi National Collegiate Honorary Society

Publications:

Bootman JL. Pharmacy Today & Tomorrow, Saudi Pharmaceutical Journal 1993; 1 (1): 38-39.

Bootman JL. Principles of Pharmacoepidemiology Saudi Pharmaceutical Journal 1993, 1(1): 43-44.

Chinburapa V, Larson L, Brucks, M, Draugalis J, Bootman, JL & Puto C: Physician Prescribing Decisions: The effects of Situational Involvement & Task Competing on Information Acquisitional Decision Making, Social Science Medicine, 1993; 36 1(1): 1473-1482.

Bootman JL, Introduction Health Care Reform - Pharmaceutical Representative, October 1993.

Bootman JL, The Clinton Health Care Reform Proposal, Pharmaceutical Representative, November 1993.

Bootman JL, The Impact of Health Care Reform, Pharmaceutical Representative, December 1993.

Mackeigan L, Larson L, Draugalis J, Bootman JL, Burns L. Time Preference for Health Gains Versus Health Losses, Pharmacoeconomics 1993: 3 (5) 374-386.

Bootman JL, Managing Conflict in the Academic Setting American Journal of Pharmaceutical Education. 1994: 58 (Spring): 1-21.

Harrison DL, Bootman JL, Strategic Planning by Institutional Pharmacy Administrators, Journal of Pharmaceutical Marketing and Management 1994: 8 (2): 73-96.

Bootman JL, Current Trends in Health Care Delivery, Pharmaceutical Representative November 1994.

Bootman JL, Changing Roles of Health Care Providers, Pharmaceutical Representative, December 1994.

Johnson J. Bootman JL, Pharmacoeconomic analysis in formulary decisions: An international perspective, Commentary, Am J Hosp Pharm. October 1994: 51, 2593-2597.

Bootman JL, Bungay K, Schulman K, The Role of Industry in Disease Management, Part II, Pharmaceutical Representative, March 1995.

Johnson J, Bootman JL, Drug Related Morbidity and Mortality in the United States, Archives of Internal Medicine, Volume 155, October 9, 1995, 1949-1956

Bootman JL. Principles of Pharmacoepidemiology, Saudi Pharmaceutical Journal 1993; 1(1): 43-44

Bootman JL, Introduction Health Care Reform, J. Pharm. Rep., 1993; 23 (12): 4-6.

Bootman JL, The Clinton Health Care Reform Proposal, J. Pharm. Rep., 1993; 23 (11): 4-6.

Bootman JL, The Impact of Health Care Reform, J. Pharm. Rep., 1993; 23(12): 4- 6.

Mackeigan L, Larson L, Draugalis J, Bootman JL, Burns L. Time Preference for Health Gains Versus Health Losses, Pharmacoeconomics 1993; 3(5): 374-386.

Bootman JL, Managing Conflict in the Academic Setting, American Journal of Pharmaceutical Education. 1994; 58(Spring): 1-21.

Harrison DL, Bootman JL, Strategic Planning by Institutional Pharmacy Administrators, Journal of Pharmaceutical Marketing and Management 1994; 8 (2): 73-96.

Bootman JL, Current Trends in Health Care Delivery, J. Pharm. Rep., 1994; 24 (11): 5-7.

Bootman JL, Changing Roles of Health Care Providers, J. Pharm. Rep., 1994; 24 (12): 4-6.

Johnson J. Bootman JL, Pharmacoeconomic analysis in formulary decisions: An international perspective, Commentary, Am J Hosp Pharm. October 1994; 51: 2593-2597.

Bootman JL, New Directions for the Pharmacist, J. Pharm. Rep., 1995; 25 (1): 4-7.

Bootman JL, Bungay K, Schulman K, Introduction to Disease Management, J. Pharm. Rep., 1995; 25(2): 4-7.

Bootman JL, Bungay K, Schulman K, The Role of Industry in Disease Management, J. Pharm. Rep., 1995; 25 (3): 4-6.

Bootman JL, Noel M, Sampling on the Line, Pharmaceutical Executive, 1995; 15 (3): 86-90.

Bootman JL, Nash D, Advanced Concepts in Managed Healthcare: Evolution of Integrated Healthcare Systems, J. Pharm. Rep., 1995; 25 (6): 4-6.

Bootman JL, Nash D, Advanced Concepts In Managed Healthcare: Models of Integrated Healthcare Delivery, J. Pharm. Rep., 1995; 25 (7): 3-5.

Bootman JL, Nash D, Advanced Concepts in Managed Healthcare: Role of the Pharmaceutical Industry in Integrated Healthcare Systems, J. Pharm. Rep., 1995; 25 (8): 4-7.

Johnson J, Bootman JL, Drug Related Morbidity and Mortality: A Cost of Illness Model, Archives of Internal Medicine, 1995; 155: October 9, 1949-1956

Bootman JL, Pharmacoeconomics and Outcomes Research, AJHP, 1995; 52 (3): July 15, 16-19.

Bootman JL, Chair Report. Academic Affairs Committee. American Journal of Pharmaceutical Education 1995; 59 (4): 1-3.

Bootman JL, Pharmacoeconomics: An Emerging Discipline for the Pharmacy Profession, Pharmacy World and Science, 1996; 18 (1): 3-4.

Bootman JL, Milne R, Costs, Innovation and Efficiency in Antiinfective Therapy, Pharmacoeconomics, 1996; 9 (Suppl-1): 31-39

Bootman JL, The $76 Billion Wake-up Call, J. Amer. Pharm. Assoc. 1996; NS36 (1): 27-28

Bootman JL, Pharmacoeconomics and Therapeutic Drug Monitoring, Marketing for Health 1996; 6 (2): 10-12.

Gouveia WA, Bootman JL, The Outcomes Movement of Its Influence as the Future of Pharmacy Practice and Research, Actes DV XXXII Congress Internationale D'Historie De La Pharmacie Proceedings, Paris, France, 1996; (2): 256-288.

Kortt MA, Bootman JL, The Economics of Benign Prostatic Hyperplasia Treatment: A Literature Review, Clinical Therapeutics, 1996; 18 (6): 1227-1241

Bootman JL, and Martin RE, Current Trends in Managed Healthcare Part I, Pharmaceutical Representatives, 1997; 27 (1): 3-5.

Bootman JL, and Martin RE, Current Trends in Managed Healthcare Part II, Pharmaceutical Representation, 1997; 27 (2): 3-5.

Johnson J, Bootman JL, Drug Related Morbidity and Mortality and the Economic Impact of Pharmaceutical Care, Am. J. Health Systems Pharmacy, 1997: 54 (Mar 1): 554-558

Bootman JL, Martin RE, Current Trends in Managed Healthcare Part III, Pharmaceutical Representative 1997; 27(2): 5-7

Bootman JL, Harrison D, Pharmacoeconomics of Therapeutic Drug Monitoring, Pharmacy World and Science, 1997; 19(3): 1-4

Bootman JL, Harrison D, Cox E, The Healthcare Cost of Drug-Related Morbidity and Mortality in Nursing Facilities, Archives of Internal Medicine, 1997: 157 (Oct 13): 2089-2096

Bootman JL, and Langley P, Pharmacoeconomics, Prescribing and Reimbursement of Pharmaceuticals, J. Applied Therapeutics, 1997; 1(1): 275-283

Bootman, JL Bungay K, Outcomes in the Health Care Marketplace, Pharmaceutical Representative 1998; 28(6): 25-28

Bootman JL, Piech C, Cost Effectiveness of Two New Treatments for onychomycosis: An Analysis of Two Comparative Clinical Trials, J. Amer. Acad. Dermatology, 1998; 38: S69-72